Tacedinaline
Tacedinaline, also known as Acetyldinaline, has been in phase III clinical trials by Pfizer for the treatment of advanced non-small cell lung cancer. Reference standards of Tacedinaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Tacedinaline
[catalogue_number] => PA 20 2950000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 269.3
[form] => C15H15N3O2
[cas] => 112522-64-2
[pslug] => 112522-64-2-tacedinaline-api-pa202950000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
